The Peptide AppField Guide · Healing SeriesSpecimen No. 677

Healing Category

MK-677

Q: What research supports this MK-677 guide?

This guide links to 2 curated or current research sources. Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

THE BUILDER

Ibutamoren; Oratrope

MK-677 is an orally active compound that mimics ghrelin and stimulates your body to produce more growth hormone and IGF-1. Unlike injecting synthetic HGH, this triggers your natural pulsatile GH release. Users report better sleep, faster recovery, increased muscle mass, and improved body composition. It's one of the most popular compounds for anti-aging and bodybuilding.

MK-677

MK-677 Evidence Snapshot

How these guides are reviewed

Regulatory status: Not FDA approved · research use only
Dosing guidance: No established regimen
Linked evidence: 2 research sources
Content updated: Sep 15, 2026

Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About MK-677

Is MK-677 FDA approved?

No. This profile records MK-677 as not FDA approved and for research use only.

More context

Review the regulatory and source details on this page for the current context.

What research supports this MK-677 guide?

This guide links to 2 curated or current research sources.

More context

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Review the MK-677 research sources

What are the side effects of MK-677?

Reported side effects of MK-677 include Increased appetite, Water retention, Joint pain, Numbness in hands, and Elevated blood sugar.

More context

They are reported or occasional reactions, not a prediction of what any one person will experience.

Is MK-677 safe?

MK-677 has an editorial safety grade of C (Moderate Safety).

More context

Generally tolerated but can affect blood sugar and cause water retention. Safety depends on dose, sourcing, health history and medical supervision, so this page does not call it safe for personal use.

Studied Effects & Mechanisms

GH Secretion

Activates ghrelin receptors to stimulate pulsatile growth hormone release

IGF-1 Elevation

Increases IGF-1 levels for muscle growth and recovery

Sleep Enhancement

Improves deep sleep quality when GH peaks

Bone Density

Supports increased bone mineral density over time

Non-peptide research origins

MK-677 is a synthetic non-peptide small molecule, despite often being grouped with peptide research compounds. Merck researchers reported its design in 1995 under the identifiers L-163,191 and MK-0677. That program compared a non-peptide chemical structure with the existing growth-hormone secretagogue research that included GHRP-6.

[Merck discovery paper, Patchett et al., 1995](https://pubmed.ncbi.nlm.nih.gov/7624358/)

Who is this for

Those wanting to increase natural growth hormone

Athletes and bodybuilders seeking muscle gains

People with poor sleep quality

Those over 30 experiencing age-related decline

Anyone wanting faster recovery from training

MK-677 Dosing

Dosage

No established SubQ regimen.

Cycle

No established SubQ dosing cycle.

Clinical Team Note

The reviewed regimen is not a SubQ regimen. No injection dose should be inferred from another route.

Get your exact syringe units with the reconstitution calculator

Reported Timeline

Week 1

Improved sleep quality and increased appetite

Week 2-4

Better recovery, possible water retention

Week 4-8

Noticeable muscle fullness and strength gains

Week 8-12

Significant body composition improvements

Sleep improvements often noticed within days; body composition changes in 4-8 weeks.

Timelines summarize reported or expected patterns and are not guaranteed individual outcomes.

MK-677 side effects and safety

Moderate Safety

Editorial grade C · Moderate

SafetyCModerate

FDA approval statusNo · research use only

Generally tolerated but can affect blood sugar and cause water retention.

May worsen insulin sensitivity. Not suitable for diabetics without medical supervision.

Possible side effects

Increased appetite · Water retention · Joint pain · Numbness in hands · Elevated blood sugar

How to interpret safety grades

The Peptide App

Set up your MK-677 schedule

Dose reminders and your schedule, ready the moment you open the app.

Commonly Stacked With

CJC-1295

MK-677 mimics ghrelin and CJC-1295 supplies GHRH, two separate triggers for GH release.

Market evidence

MK-677 product testing and COAs

We found certificates from some of the MK-677 vendors we track. Based on the certificates our crawler found; vendors may publish more than we index. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.

View vendor COAs and pricing →Testing database How to read a COA

MK-677 research

[1]Ibutamoren in GH-Deficient Adults - Clinical Trial [2]Merck discovery paper, Patchett et al., 1995

The clinic network

Want a clinician's view on MK-677?

Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves

Find a peptide clinic